−42.1
Larimar Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
−27.6
FY23:
−33.5
FY24:
−70.8
FY25:
−113
Change from FY21 to FY25
millions USD
FY21:
24.2
FY22:
−91.0
FY23:
33.4
FY24:
−85.4
FY25:
100
Change from FY21 to FY25
millions USD
FY21:
19.9
FY22:
75.3
FY23:
0.03
FY24:
162
FY25:
65.1
millions USD
FY21:
1.95
FY22:
−43.3
FY23:
−0.08
FY24:
5.74
FY25:
52.2
(positive)
Change from FY21 to FY25
millions USD
FY21:
−42.4
FY22:
−27.7
FY23:
−33.6
FY24:
−71.3
FY25:
−113
All amounts in millions USD